Publicacions en col·laboració amb investigadors/es de University of Padua (45)

2024

  1. Analytical treatment interruption in children living with HIV: position statement from the EPIICAL consortium

    The Lancet HIV, Vol. 11, Núm. 10, pp. e700-e710

  2. Factors Associated With Coronary Angiography Performed Within 6 Months of Randomization to the Conservative Strategy in the ISCHEMIA Trial

    Circulation: Cardiovascular Interventions, Vol. 17, Núm. 6, pp. 457-473

  3. IMpassion132 double-blind randomised phase III trial of chemotherapy with or without atezolizumab for early relapsing unresectable locally advanced or metastatic triple-negative breast cancer

    Annals of Oncology, Vol. 35, Núm. 7, pp. 630-642

  4. Low unspliced cell-associated HIV RNA in early treated adolescents living with HIV on long suppressive ART

    Frontiers in Immunology, Vol. 15

  5. Navigating practical challenges in immunotherapy for metastatic triple negative breast cancer

    Cancer Treatment Reviews, Vol. 128

  6. Sustained aviremia despite anti-retroviral therapy non-adherence in male children after in utero HIV transmission

    Nature Medicine

  7. Technical Design Report for the LUXE experiment

    European Physical Journal: Special Topics

2023

  1. Association of HER2DX with pathological complete response and survival outcomes in HER2-positive breast cancer

    Annals of Oncology, Vol. 34, Núm. 9, pp. 783-795

  2. Effective early antiretroviral therapy in perinatal-HIV infection reduces subsequent plasma inflammatory profile

    Pediatric Research, Vol. 94, Núm. 5, pp. 1667-1674

  3. Pathologic Complete Response and Individual Patient Prognosis After Neoadjuvant Chemotherapy Plus Anti-Human Epidermal Growth Factor Receptor 2 Therapy of Human Epidermal Growth Factor Receptor 2-Positive Early Breast Cancer

    Journal of clinical oncology : official journal of the American Society of Clinical Oncology, Vol. 41, Núm. 16, pp. 2998-3008

  4. Re-Evaluation of Pathologic Complete Response as a Surrogate for Event-Free and Overall Survival in Human Epidermal Growth Factor Receptor 2-Positive, Early Breast Cancer Treated With Neoadjuvant Therapy Including Anti-Human Epidermal Growth Factor Receptor 2 Therapy

    Journal of clinical oncology : official journal of the American Society of Clinical Oncology, Vol. 41, Núm. 16, pp. 2988-2997

  5. Techniques to improve the accuracy of complete arch implant intraoral digital scans: A systematic review

    Journal of Prosthetic Dentistry, Vol. 129, Núm. 6, pp. 844-854

2022

  1. Clinical, Virological and Immunological Subphenotypes in a Cohort of Early Treated HIV-Infected Children

    Frontiers in Immunology, Vol. 13

  2. Determinants of B-Cell Compartment Hyperactivation in European Adolescents Living With Perinatally Acquired HIV-1 After Over 10 Years of Suppressive Therapy

    Frontiers in immunology, Vol. 13, pp. 860418

  3. Development and validation of the new HER2DX assay for predicting pathological response and survival outcome in early-stage HER2-positive breast cancer

    eBioMedicine, Vol. 75

  4. Machine learning outperformed logistic regression classification even with limit sample size: A model to predict pediatric HIV mortality and clinical progression to AIDS

    PloS one, Vol. 17, Núm. 10, pp. e0276116

  5. Optimizing the World Health Organization algorithm for HIV vertical transmission risk assessment by adding maternal self-reported antiretroviral therapy adherence

    BMC public health, Vol. 22, Núm. 1, pp. 1312

  6. Thalassaemia is paradoxically associated with a reduced risk of in-hospital complications and mortality in COVID-19: Data from an international registry

    Journal of Cellular and Molecular Medicine, Vol. 26, Núm. 9, pp. 2520-2528

  7. Trends of Phase I Clinical Trials in the Latest Ten Years across Five European Countries

    International Journal of Environmental Research and Public Health, Vol. 19, Núm. 21

2021

  1. A novel circulating microRNA for the detection of acute myocarditis

    New England Journal of Medicine, Vol. 384, Núm. 21, pp. 2014-2027